Episode 54: Balancing Act: GLP-1 Breakthroughs and the Impact on CPGs
Kantar Retail Sound Bites

Episode 54: Balancing Act: GLP-1 Breakthroughs and the Impact on CPGs

Feb 21, 2024
1:01:31
-(0)

About this episode

In episode 54 of Kantar's Retail Sound Bites, Barry Thomas, senior retail thought leader, and Rachel Dalton, head of retail insights, discuss the rise of GLP-1 weight-loss drugs and the forecasted implications on the food and beverage industries with Leigh O'Donnell, head of shopper and category insights, and Patricia Gregory, global analytics lead, at Kantar. Have a topic you'd like us to cover? Contact us at Kantar's Retail Sound Bites Podcast. Learn more about GLP-1, other injectable medication usage, and shopper attitudes in our latest study GLP-1 & Injectable Medications . Barry's contact information: barry.thomas@kantar.com Barry's LinkedIn Rachel's contact information: rachel.dalton@kantar.com Rachel's LinkedIn

Comments

Rate this episode

Episode Details

Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy